微RNAs作为在骨髓肉瘤中对西斯普拉丁耐药性的关键调节者
1Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Pathology, research and practice
|August 7, 2023
概括
微RNAs (miRNAs) 通过调节药物反应途径,可以克服骨髓瘤 (OS) 中的西斯普拉丁耐药性. 这些miRNA显示出作为预测OS患者治疗有效性的生物标志物具有前景.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 骨髓瘤 (OS) 是一种主要的骨癌,影响年轻人,通常用西斯 (CDDP) 治疗.
- 西斯普拉丁耐药性是一个重大的临床挑战,限制了治疗疗效,并导致严重的副作用.
- 了解CDDP耐药性的分子机制对于开发新的治疗策略至关重要.
研究的目的:
- 在骨髓瘤 (OS) 细胞中审查和讨论与西斯普拉丁 (CDDP) 反应相关的微RNA (miRNA).
- 阐明miRNAs在调节CDDP耐药性和敏感性的作用.
- 突出miRNAs作为潜在的生物标志物,用于预测OS中的CDDP反应.
主要方法:
- 关于研究miRNAs和CDDP响应在骨髓瘤中的研究的文献综述.
- 对参与多药性耐药性 (MDR) 的细胞过程的miRNA介导调节的分析.
- 综合了关于miRNAs如何影响药物排放,解毒,信号通路,亡和自的发现.
主要成果:
- 大多数已识别的miRNA增强了OS细胞中的CDDP敏感性.
- 这些miRNAs调节关键通路,包括信号传递,亡,药物运输和自.
- miRNAs与克服骨髓瘤多药性耐药性 (MDR) 机制有关.
结论:
- 微RNA在调节骨髓瘤中西斯普拉丁敏感性和耐药性方面发挥着重要作用.
- miRNAs为针对CDDP抗性OS的新型治疗干预提供了一个有希望的途径.
- miRNAs可以作为可靠的非侵入性生物标志物,用于预测骨髓瘤患者的CDDP治疗反应.
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
02:15Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K